here - Texas Healthcare & Bioscience Institute

Working Agenda
(Subject to Change)
2015 SUMMIT AND LUMINARY DINNER AGENDA
HEALTH & HUMAN SERVICES EXECUTIVE COMMISSIONER DR. KYLE JANEK, CHAIRMAN
DAY 1: FEBRUARY 4, 2015 – SHERATON HOTEL
DAY 2: FEBRUARY 5, 2015 – THE TEXAS CAPITOL
AUSTIN, TEXAS
DAY 1 – FEBRUARY 4
10:00 AM to 5:30 PM

CHAIRMAN’S WELCOME
o David Margrave, BioNumerik Pharmaceuticals, Inc.

OPENING KEYNOTE
o

THE FUTURE LANDSCAPE OF THE TEXAS LIFESCIENCES INDUSTRY
o
o
o
o

John Burns, Ph.D., President/General Counsel, BioAustin
JJ Spegele, President/CEO, Bio North Texas
Jacqueline Northcut, President/CEO, BioHouston
Ann Stevens, President/CEO, BioMedSA
Todd McDaniel, President/CEO, The Research Valley Partnership
DRUG DEVELOPMENT AND CLINICAL TRIALS
o
o
o
o
o

Representative Sarah Davis, Texas House of Representatives
Representative Donna Howard, Texas House of Representatives
Representative Jim Murphy, Texas House of Representatives
Executive Commissioner Kyle Janek, M.D., Texas Health and Human Services Commission
(Moderator)
UPDATE FROM REGIONAL BIO LEADERSHIP
o
o
o
o
o

Brett Giroir, M.D., CEO, Texas A&M Health Science Center
DISCUSSIONS WITH STATE LEADERS ON CURRENT AND FUTURE LEGISLATIVE
PRIORITIES
o
o
o
o

Wayne Roberts, CEO, Cancer Prevention & Research Institute of Texas (CPRIT)
Margaret Sampson, Partner, Vinson & Elkins, LLP
Paul Lammers, M.D., President/CEO, Mirna Therapeutics
Tom Kowalski, President/CEO, Texas Healthcare and Bioscience Institute (Moderator)
LUNCH KEYNOTE – An Update from the “Task Force on Infectious Disease Preparedness
and Response”
o

The Honorable James (Jim) Greenwood, President/CEO, Biotechnology Industry Organization
(BIO)
Giulio Draetta, M.D., Ph.D., The University of Texas M.D. Anderson Cancer Center
Andrew Strong, President/CEO, Kalon Biotherapeutics, LLC
Kim Warren, Ph.D., Senior Director for Business Development, Sanofi
Maninder Kahlon, Ph.D., Vice Dean of Strategy and Partnerships, Dell Medical School (invited)
Patricia Hurn, Ph.D., Vice Chancellor for Research/Innovation, The University of Texas System
(Moderator)
INDUSTRY CEO DISCUSSION
o
o
Robert (Bob) Gracy, Ph.D., President/CEO, Texas Biomedical Research Institute (invited)
Israel Rocha, Jr., CEO, Doctors Hospital at Renaissance
o
o

Matt Winkler, Chairman/Scientific Officer, Asuragen
Evan Melrose, M.D., Founding Managing Director, Spindletop Capital (Moderator)
CLOSING KEYNOTE
o Stephen (Steve) Ubl, President/CEO, AdvaMed
5:30 PM
VIP / GENERAL RECEPTIONS
7:00 PM
LUMINARY DINNER

HONOREES
o
o
Executive Commissioner Kyle Janek, M.D., Texas Health and Human Services Commission
Dennis Borel, Executive Director, Coalition of Texans with Disabilities
DAY 2 – FEBRUARY 5
8:00 AM to 12:00 PM

BREAKFAST KEYNOTE
o
Representative John Zerwas, M.D., Texas House of Representatives

SENIOR STAFF LEGISLATIVE PANEL

BIOTEXAS FLY-IN
12:00 PM
CLOSING LUNCH